These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 11607766

  • 1. Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions.
    van Besien K, Koshy M, Anderson-Shaw L, Talishy N, Dorn L, Devine S, Yassine M, Kodish E.
    Bone Marrow Transplant; 2001 Sep; 28(6):545-9. PubMed ID: 11607766
    [Abstract] [Full Text] [Related]

  • 2. A survey on patient perception of reduced-intensity transplantation in adults with sickle cell disease.
    Chakrabarti S, Bareford D.
    Bone Marrow Transplant; 2007 Apr; 39(8):447-51. PubMed ID: 17334383
    [Abstract] [Full Text] [Related]

  • 3. Bone marrow transplantation for sickle cell disease. A study of parents' decisions.
    Kodish E, Lantos J, Stocking C, Singer PA, Siegler M, Johnson FL.
    N Engl J Med; 1991 Nov 07; 325(19):1349-53. PubMed ID: 1922237
    [Abstract] [Full Text] [Related]

  • 4. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ, Mahabali SD, Stiggelbout AM, Sont JK, van Laar JM.
    J Rheumatol; 2002 Aug 07; 29(8):1653-8. PubMed ID: 12180724
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Current attitudes of parents and patients toward hematopoietic stem cell transplantation for sickle cell anemia.
    Meier ER, Dioguardi JV, Kamani N.
    Pediatr Blood Cancer; 2015 Jul 07; 62(7):1277-84. PubMed ID: 25809231
    [Abstract] [Full Text] [Related]

  • 8. Therapy preference and decision-making among patients with severe sickle cell anemia and their families.
    Hankins J, Hinds P, Day S, Carroll Y, Li CS, Garvie P, Wang W.
    Pediatr Blood Cancer; 2007 Jun 15; 48(7):705-10. PubMed ID: 16732581
    [Abstract] [Full Text] [Related]

  • 9. Nonmyeloablative approaches to the treatment of sickle hemoglobinopathies.
    Amado RG, Schiller GJ.
    Semin Oncol; 2000 Apr 15; 27(2 Suppl 5):82-9. PubMed ID: 10877059
    [Abstract] [Full Text] [Related]

  • 10. Will developments in allogeneic transplantation influence treatment of adult patients with sickle cell disease?
    Chakrabarti S, Bareford D.
    Biol Blood Marrow Transplant; 2004 Jan 15; 10(1):23-31. PubMed ID: 14752776
    [Abstract] [Full Text] [Related]

  • 11. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
    Valcárcel D, Martino R, Sureda A, Canals C, Altés A, Briones J, Sanz MA, Parody R, Constans M, Villela SL, Brunet S, Sierra J.
    Eur J Haematol; 2005 Feb 15; 74(2):144-51. PubMed ID: 15654906
    [Abstract] [Full Text] [Related]

  • 12. Allogeneic transplantation for haemoglobinopathies.
    Vassiliou G, Amrolia P, Roberts IA.
    Best Pract Res Clin Haematol; 2001 Dec 15; 14(4):807-22. PubMed ID: 11924923
    [Abstract] [Full Text] [Related]

  • 13. Stem cell transplant for children with sickle cell anemia: parent and patient interest.
    Roth M, Krystal J, Manwani D, Driscoll C, Ricafort R.
    Biol Blood Marrow Transplant; 2012 Nov 15; 18(11):1709-15. PubMed ID: 22659467
    [Abstract] [Full Text] [Related]

  • 14. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.
    Biol Blood Marrow Transplant; 2009 Jan 15; 15(1):30-8. PubMed ID: 19135940
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Favorable outcome with allogeneic hematopoietic stem cell transplantation in pediatric acquired aplastic anemia patients.
    Unal S, Cetin M, Tavil B, Calişkan N, Yetgin S, Uçkan D.
    Pediatr Transplant; 2007 Nov 15; 11(7):788-91. PubMed ID: 17910658
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation.
    Shapira MY, Or R, Resnick IB, Bitan M, Ackerstein A, Samuel S, Elad S, Zilberman I, Miron S, Slavin S.
    Bone Marrow Transplant; 2003 Sep 15; 32(6):557-61. PubMed ID: 12953126
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.